HighTide Therapeutics to Present Phase 2 Results of HTD1801 in NASH Patients Co-Morbid with Type 2 Diabetes at NASH Summit
HTD1801 met primary endpoint in Phase 2 trial with statistically significant reduction in liver fat…
HTD1801 met primary endpoint in Phase 2 trial with statistically significant reduction in liver fat…
TOKYO AND LONDON--(BUSINESS WIRE)--#cryptotrading--SBI Financial Services, the subsidiary of SBI Holdings (“SBI”), today announced the…
Silicon Valley-based Plus and China’s dominant “Uber for Trucks” platform Full Truck Alliance collaborate to…
The company will also exhibit the latest updates to its industry-leading FaceMe® SDK, as well…
NEW YORK & LONDON & MELBOURNE--(BUSINESS WIRE)--CUBE, a global technology company transforming regulatory compliance for…
The new SUSS location in the state-funded Science Park in Hsinchu, Taiwan consists of an…
? If approved, TAK-721 will be the first FDA-approved treatment for the chronic inflammatory disease;…
EGS’s 2020 GlobalVue™ Report Reveals Significant Ranking Changes of 41 Different Countries IRVINE, Calif.--(BUSINESS WIRE)--Edwards…
Report also found that the catch rate for selfie fraud was five times greater than…
New ZMOD4410 IAQ Sensor Enables Operation in Splash-Prone Areas, Delivering Cost-Effective Solution for Water- and…